These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16910577)

  • 1. [Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone].
    Miyazawa Y; Irisawa H; Uchiumi H; Saitoh T; Handa H; Matsushima T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
    Rinsho Ketsueki; 2006 Jul; 47(7):656-60. PubMed ID: 16910577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
    Talamo GP; Ibrahim S; Claxton D; Tricot GJ; Fink LM; Zangari M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):337-9. PubMed ID: 19367157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamic MRI of the bone marrow for monitoring multiple myeloma during treatment with thalidomide as monotherapy or in combination with CED chemotherapy].
    Wasser K; Moehler T; Neben K; Nosas S; Heiss J; Goldschmidt H; Hillengass J; Düber C; Kauczor HU; Delorme S
    Rofo; 2004 Sep; 176(9):1285-95. PubMed ID: 15346264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma.
    Murakami H; Handa H; Abe M; Iida S; Ishii A; Ishikawa T; Ishida T; Oota M; Ozaki S; Kosaka M; Sakai A; Sawamura M; Shimazaki C; Shimizu K; Takagi T; Hata H; Fukuhara T; Fujii H; Miyata A; Wakayama T; Takatsuki K
    Eur J Haematol; 2007 Sep; 79(3):234-9. PubMed ID: 17655699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide and dexamethasone: therapy for multiple myeloma.
    Kumar S; Rajkumar SV
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):759-66. PubMed ID: 16221046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma.
    Dimopoulos MA; Hamilos G; Zomas A; Gika D; Efstathiou E; Grigoraki V; Poziopoulos C; Xilouri I; Zorzou MP; Anagnostopoulos N; Anagnostopoulos A
    Hematol J; 2004; 5(2):112-7. PubMed ID: 15048060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation.
    Zangari M; Barlogie B; Anaissie E; Saghafifar F; Eddlemon P; Jacobson J; Lee CK; Thertulien R; Talamo G; Thomas T; Van Rhee F; Fassas A; Fink L; Tricot G
    Br J Haematol; 2004 Sep; 126(5):715-21. PubMed ID: 15327525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Brief report: stroke in multiple myeloma patient treated with thalidomide].
    Ito Y; Mori A; Yonemura K; Hashimoto Y; Hirano T; Uchino M
    Rinsho Shinkeigaku; 2007 Sep; 47(9):593-6. PubMed ID: 18018619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy.
    Hazarika M; Rock E; Williams G; Dagher R; Sridhara R; Booth B; Farrell A; Justice R; Pazdur R
    Oncologist; 2008 Oct; 13(10):1120-7. PubMed ID: 18922829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.
    Chim CS
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):181-2. PubMed ID: 17846773
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone.
    Klein U; Kosely F; Hillengass J; Hundemer M; Schmitt S; Neben K; Moehler T; Hegenbart U; Ho AD; Goldschmidt H
    Ann Hematol; 2009 Jan; 88(1):67-71. PubMed ID: 18668241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide and thrombosis. A meta-analysis.
    El Accaoui RN; Shamseddeen WA; Taher AT
    Thromb Haemost; 2007 Jun; 97(6):1031-6. PubMed ID: 17549307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary embolism in a patient with multiple myeloma receiving thalidomide-dexamethasone therapy.
    Jeng WJ; Kuo MC; Shih LY; Chu PH
    Int J Hematol; 2008 Jun; 87(5):542-544. PubMed ID: 18414984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide: new drug. Myeloma: many questions remain unanswered.
    Prescrire Int; 2008 Dec; 17(98):230-2. PubMed ID: 19422142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide for the treatment of multiple myeloma.
    Hattori Y; Iguchi T
    Congenit Anom (Kyoto); 2004 Sep; 44(3):125-36. PubMed ID: 15327481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
    Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T
    Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy.
    Minnema MC; Breitkreutz I; Auwerda JJ; van der Holt B; Cremer FW; van Marion AM; Westveer PH; Sonneveld P; Goldschmidt H; Lokhorst HM
    Leukemia; 2004 Dec; 18(12):2044-6. PubMed ID: 15470485
    [No Abstract]   [Full Text] [Related]  

  • 18. Arterial and venous thrombotic complications with thalidomide in multiple myeloma.
    Alkindi S; Dennison D; Pathare A
    Arch Med Res; 2008 Feb; 39(2):257-8. PubMed ID: 18164975
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pulmonary embolism as a first manifestation of synchronous occurrence of two neoplasms].
    Elikowski W; Lewandowska M; Małek M; Krokowicz P; Piotrowska-Stelmaszyk G; Zawilska K
    Kardiol Pol; 2009 Nov; 67(11):1262-6; discussion 1267. PubMed ID: 20024855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience.
    Zheng W; Wei G; Ye X; He J; Li L; Wu W; Shi J; Zhang J; Huang W; Xie W; Luo Y; Xue X; Lin M; Huang H; Cai Z
    Leuk Res; 2009 Dec; 33(12):1615-8. PubMed ID: 19773080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.